Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use iDose® TR safely and effectively. See full prescribing information for iDose® TR. iDose® TR (travoprost intracameral implant), for intracameral administration Initial U.S. Approval: 2001
Medication labelWhy this: Advisory · dailymed-prescription
iDose® TR (travoprost intracameral implant) is indicated for the reduction of intraocular pressure (IOP) in patients with open-angle glaucoma (OAG) or ocular hypertension (OHT).
- generic_name
- travoprost intracameral
- product_names
- Travoprost Intracameral
- ndc
- 25357-100, 25357-100-01, 25357-100-99
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en